A broad licensing and research alliance will hand Sarepta four clinical-stage candidates, while Arrowhead receives $500 ...

While on set of “Holiday Touchdown,” Hallmark and the Kansas City Chiefs’ football romance, TODAY learned from those behind ...

See all the top highlights from the Kansas #Jayhawks’ win over Coach Prime and the Colorado #Buffaloes at Arrowhead Stadium ...

Arrowhead has entered a worldwide licensing and partnership agreement with Sarepta Therapeutics for rare genetic disease ...

No. 16 Colorado is bringing an 'iced out' look to Arrowhead Stadium this weekend for their critical Big 12 showdown against ...

Just as the Colorado balloon was filling up with current success and future possibilities, Kansas popped it on Saturday at ...

The Jayhawks answered with a touchdown of their own and finally forced a Colorado three-and-out. On KU’s second drive of the ...

Fans attending the Chiefs Black Friday game to get special "Holiday Touchdown: A Chiefs Love Story" branded pennant.

Sarepta Therapeutics said it will pay Arrowhead Pharmaceuticals $500 million in cash for a series of experimental RNA-based ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its 2024 fiscal year ended September 30, 2024. The Company is hosting a conference ...

After Sarepta (SRPT) announced a global licensing and collaboration agreement with Arrowhead (ARWR) that adds four clinical-stage siRNA assets ...

Shares of Sarepta Therapeutics SRPT rose nearly 14% on Tuesday after announcing that it has entered into an exclusive global licensing and collaboration agreement with Arrowhead Pharmaceuticals ...